{
  "url": "https://openlegislation.uk/draft-controlled-drugs-drug-precursors-amendment-and-revocation-regulations-2026/regulation-6",
  "json_url": "https://openlegislation.uk/draft-controlled-drugs-drug-precursors-amendment-and-revocation-regulations-2026/regulation-6.json",
  "legislation": "ukdsi/2026/9780348279917",
  "legislation_title": "The Controlled Drugs (Drug Precursors) (Amendment and Revocation) Regulations 2026",
  "legislation_url": "https://openlegislation.uk/draft-controlled-drugs-drug-precursors-amendment-and-revocation-regulations-2026",
  "path": "regulation/6",
  "kind": "regulation",
  "number": "6",
  "heading": "Amendment of Council Regulation (EC) 111/2005",
  "text": "(1) Council Regulation (EC) 111/2005 of 22 December 2004 laying down rules for the monitoring of trade between the Union and third countries in drug precursors is amended as follows.\n(2) In Article 1 (subject matter)—\n(a) for “the United Kingdom” substitute in both places it occurs “Great Britain”;\n(b) in both places in occurs after “third countries” insert “or Northern Ireland”.\n(3) In Article 2 (definitions)—\n(a) in paragraphs (c), (d) and (e), for “the United Kingdom”, in each place it occurs substitute “Great Britain”;\n(b) for paragraph (j) substitute—\n“(j) ‘natural product’ means—\n(i) an organism or a part thereof, in any form; or\n(ii) a naturally occurring substance which is unprocessed or processed only by manual, mechanical or gravitational means, by dissolution in water, by flotation, by extraction with water, by steam distillation or by heating solely to remove water, or which is extracted from air by any means.”.\n(4) In Article 6 (licensing) in paragraph (1), for “the United Kingdom” substitute “Great Britain”.\n(5) In Article 7 (registration) in paragraph (1) for “the United Kingdom” substitute “Great Britain”.\n(6) In Article 8 (demonstration of licit purposes) in paragraphs (1) and (2) for “the United Kingdom” substitute “Great Britain”.\n(7) In Article 9 (provision of information) in paragraph (1) for “the United Kingdom” substitute “Great Britain”.\n(8) In Article 10 (guidelines) in paragraph (1) for “the United Kingdom” substitute “Great Britain”.\n(9) In Article 11 (pre-export notification)—\n(a) other than in the third place it occurs in paragraph 1 in each place it occurs after “country of destination” insert “or Northern Ireland”;\n(b) in the second place it occurs in paragraph 1 after “countries of destination” insert “which may include Northern Ireland,”;\n(c) in paragraph 2 after “in the third country” insert “or Northern Ireland”.\n(10) In Article 12 (export authorisation) in paragraph (1) for “the United Kingdom” substitute “Great Britain”.\n(11) In Article 13 (application for export authorisation) in paragraph 1—\n(a) in sub-paragraph (a) after “in the third country” insert “or Northern Ireland”;\n(b) in sub-paragraph (d)—\n(i) for “United Kingdom” substitute “Great Britain”;\n(ii) after “importing country” insert “or Northern Ireland”;\n(c) in sub-paragraph (e) after “the country of destination” insert “or Northern Ireland”.\n(12) In Article 14 (presentation of export authorisation at point of exit)—\n(a) in paragraphs (1) and (2) in each place it occurs for “the United Kingdom” substitute “Great Britain”;\n(b) in paragraph (2) after “to the third country of destination insert “or Northern Ireland”.\n(13) In Article 15 (refusal of export authorisation) in sub-paragraph (c) after “the country of destination” insert “or Northern Ireland”.\n(14) In Article 17 (authorisation of exports)—\n(a) after “third country” in the second and third place it occurs insert “or the competent authorities of Northern Ireland”;\n(b) for “the United Kingdom” in the second place it occurs substitute “Great Britain”.\n(15) In Article 18 (period of validity of export authorisation) for “the United Kingdom” substitute “Great Britain”.\n(16) In Article 20 (import authorisation) for “the United Kingdom” substitute “Great Britain”.\n(17) In Article 21 (application for import authorisation) after “of the third country” insert “or Northern Ireland”.\n(18) In Article 22 (presentation of import authorisation) for “the United Kingdom” substitute “Great Britain.”.\n(19) In Article 25 (period of validity of import authorisation) for “the United Kingdom” substitute “Great Britain.”.\n(20) In Article 26 (powers of competent authority)—\n(a) in paragraphs 1 and 3a for “the United Kingdom” substitute “Great Britain”;\n(b) in paragraph 5 after the first sentence insert “Such fees shall be prescribed in regulations made by the Secretary of State.”.\n(21) In Article 28 (delegated acts to ensure effective monitoring of trade)—\n(a) for “the United Kingdom” substitute “Great Britain”;\n(b) after “third countries” insert “or Northern Ireland”.\n(22) Article 30a (delegated acts) after “Annex hereto” insert “to adapt”.\n(23) Omit Article 33 (processing of personal data).\n(24) In the Annex—\n(a) for the table headed “Category 1” substitute—\nSubstance\nCN designation (if different)\nCN Code (1)\nCAS No (2)\n1-Phenyl-2-propanone\nPhenylacetone\n2914 31 00\n103-79-7\nDiethyl (phenylacetyl) propanedioate (also referred to as DEPAPD)\n2918 30 00\n20320-59-6\nMethyl alpha-phenylacetoacetate (also referred to as MAPA)\n2918 30 00\n16648-44-5\nEthyl alpha-phenylacetoacetate (also referred to as EAPA) (4)\nEx 2918 30 00\n5413-05-8\n2-methyl-3-phenyloxirane-2-carboxylic acid (also referred to as BMK glycidic acid) (6)\n2918 99 90\n25547-51-7\nN-acetylanthranilic acid\n2-Acetamidobenzoic acid\n2924 23 00\n89-52-1\nAlpha-phenylacetoacetamide (also referred to as APAA)\n2924 29 70\n4433-77-6\nAlpha-phenylacetoacetonitrile (also referred to as APAAN)\n2926 40 00\n4468-48-8\nIsosafrol (cis+trans)\n2932 91 00\n120-58-1\n3,4-Methylenedioxyphenylpropan-2-one\n1-(1,3-Benzodioxol-5-yl)propan-2-one\n2932 92 00\n4676-39-5\nPiperonal\n2932 93 00\n120-57-0\nSafrole\n2932 94 00\n94-59-7\nMethyl 3-oxo-2-(3,4-methylenedioxyphenyl)butanoate (also referred to as MAMDPA) (5)\nMethyl 3-oxo-2-(3,4-methylenedioxyphenyl)butanoate\nEx 2932 99 00\n1369021-80-6\n3-(1,3-benzodioxol-5-yl)-2-methyl-oxirane-2-carboxylic acid (also referred to as PMK glycidic acid) (7)\n2932 99 00\n2167189-50-4\nIsopropylidene (2-(3,4-methylenedioxyphenyl)acetyl)malonate (also referred to as IMDPAM) (8)\nIMDPAM\n2932 99 00\nN-phenyl-1-(2-phenylethyl)piperidin-4-amine\n4-anilino-N- phenethylpiperidine (ANPP)\n2933 36 00\n21409-26-7\n1-(2-phenylethyl)piperidin-4-one\nN-phenethyl-4-piperidone (NPP)\n2933 37 00\n39742-60-4\nN-phenylpiperidin-4-amine (also referred to as 4-AP)\n2933 39 99\n23056-29-3\nTert-butyl 4-anilinopiperidine-1-carboxylate (also referred to as 1-boc-4-AP)\n2933 39 99\n125541-22-2\nN-phenyl-N-(piperidin-4-yl)propanamide (also referred to as norfentanyl)\n2933 39 99\n1609-66-1\n4-piperidone\nPiperidin-4-one\n2933 39 99\n41661-47-6\n1-boc-4-piperidone\ntert-butyl 4-oxopiperidine-1-carboxylate\n2933 39 99\n79099-07-3\nEphedrine\n2939 41 00\n299-42-3\nPseudoephedrine\n2939 42 00\n90-82-4\nNorephedrine\n>2939 44 00\n14838-15-4\nErgometrine\n2939 61 00\n60-79-7\nErgotamine\n2939 62 00\n113-15-5\nLysergic acid\n2939 63 00\n82-58-6\n(1R,2S)-(-)-chloroephedrine\n2939 79 90\n110925-64-9\n(1S,2R)-(+)-chloroephedrine\n2939 79 90\n1384199-95-4\n(1S,2S)-(+)-chloropseudoephedrine\n2939 79 90\n73393-61-0\n(1R,2R)-(-)-chloropseudoephedrine\n2939 79 90\n771434-80-1\nThe stereoisomeric forms of the substances listed in this Category not being cathine (3) whenever the existence of such forms is possible.\nThe salts of the substances listed in this Category whenever the existence of such salts is possible and not being the salts of cathine.\n(1) OJ No. L 290, 28.10.2002, p. 1.\n(2) The CAS No is the ‘Chemical abstracts service registry number’, which is a unique numeric identifier specific to each substance and its structure. The CAS No is specific to each isomer and to each salt of each isomer. The CAS Nos for the salts of the substances listed above will be different from those given.\n(3) Also named (+)-norpseudoephedrine, CN code 2939 43 00, CAS No 492-39-7.\n(4)Also known as ethyl 3-oxo-2-phenylbutanoate, according to The International Union of Pure and Applied Chemistry (IUPAC).\n(5) Also known as methyl 2-(2H-1,3-benzodioxol-5-yl)-3-oxobutanoate, according to IUPAC.\n(6)And its ethyl, methyl (CAS No 80532-66-7), propyl, isopropyl, butyl, isobutyl, sec-butyl and tert-butyl esters, with the same CN code as BMK glycidic acid.\n(7)And its ethyl (CAS No 28578-16-7), methyl (CAS No 13605-48-6), propyl, isopropyl, butyl, isobutyl, sec-butyl and tert-butyl esters, with the same CN code as PMK glycidic acid.\n(8)Also known as 5-[2-(1,3-benzodioxol-5-yl)acetyl]–2,2-dimethyl–1,3-dioxane–4,6-dione, according to IUPAC.\n(b) for the table headed “Category 2” substitute—\nSubstance\nCN designation (if different)\nCN Code (1)\nCAS No (2)\nRed phosphorus\n2804 70 10\n7723-14-0\nAcetic anhydride\n2915 24 00\n108-24-7\nPhenylacetic acid\n2916 34 00\n103-82-2\nAnthranilic acid\n2922 43 00\n118-92-3\nPiperidine\n2933 32 00\n110-89-4\nPotassium permanganate\n2841 61 00\n7722-64-7\nThe salts of the substances listed in this Category whenever the existence of such salts is possible.\n(1) OJ No. L 290, 28.10.2002, p. 1.\n(2) The CAS No is the ‘Chemical abstracts service registry number’, which is a unique numeric identifier specific to each substance and its structure. The CAS No is specific to each isomer and to each salt of each isomer. The CAS Nos for the salts of the substances listed above will be different from those given.",
  "extent": null,
  "status": null,
  "version": "current",
  "annotations": [],
  "outstanding_effects": [],
  "provenance": {
    "source": "legislation.gov.uk",
    "source_url": "https://www.legislation.gov.uk/ukdsi/2026/9780348279917/regulation/6",
    "retrieved_at": "2026-10-30T14:37:46.652464+00:00"
  },
  "licence": "Open Government Licence v3.0",
  "licence_url": "https://www.nationalarchives.gov.uk/doc/open-government-licence/version/3/",
  "attribution": "Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives."
}